Deep knowledge on 
 small-molecule drugs and 
 the 110,000 global patents 
 covering them 

Free Patent Expiration Alerts


Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Paricalcitol - Generic Drug Details

« Back to Dashboard
Paricalcitol is the generic ingredient in two branded drugs marketed by Abbvie, Sandoz Canada Inc, Lotus Pharm Co Ltd, Dr Reddys Labs Ltd, Hikma Pharms, Rising Pharms Inc, Amneal Pharms, Teva Pharms Usa, Bionpharma Inc, Hospira Inc, Aurobindo Pharma Ltd, and Accord Hlthcare, and is included in thirteen NDAs. There are three patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

This ingredient has fifteen patent family members in ten countries.

There are ten drug master file entries for paricalcitol. Fourteen suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: paricalcitol

Tradenames:2
Patents:3
Applicants:12
NDAs:13
Drug Master File Entries: see list10
Suppliers / Packaging: see list14
Therapeutic Class:Metabolic Bone Disease Agents
Formulation / Manufacturing:see details

Pharmacology for Ingredient: paricalcitol

Ingredient-typeCholecalciferol
Drug ClassVitamin D3 Analog

Tentative approvals for PARICALCITOL

Applicant Application No. Form Dosage
<disabled><disabled>INJECTABLE; INJECTION2MCG/ML
<disabled><disabled>INJECTABLE; INJECTION5MCG/ML
<disabled><disabled>INJECTABLE; INJECTION10MCG/ML

Clinical Trials for: paricalcitol

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms
PARICALCITOL
paricalcitol
CAPSULE;ORAL204327-001Jan 13, 2016RXNo<disabled><disabled>
Hikma Pharms
PARICALCITOL
paricalcitol
SOLUTION;INTRAVENOUS205917-001Nov 18, 2014RXNo<disabled><disabled>
Hikma Pharms
PARICALCITOL
paricalcitol
SOLUTION;INTRAVENOUS205917-002Nov 18, 2014RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: paricalcitol

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
ZEMPLAR
paricalcitol
SOLUTION;INTRAVENOUS020819-003Feb 1, 20005,597,815*PED<disabled>
Abbvie
ZEMPLAR
paricalcitol
CAPSULE;ORAL021606-002May 26, 20055,597,815*PED<disabled>
Abbvie
ZEMPLAR
paricalcitol
SOLUTION;INTRAVENOUS020819-001Apr 17, 19985,587,497*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: paricalcitol

Country Document Number Estimated Expiration
Japan2011037860<disabled in preview>
Japan2014129360<disabled in preview>
Japan5548079<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PARICALCITOL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB04/003United Kingdom<disabled>PRODUCT NAME: PARICALCITOL; REGISTERED: ES SPAIN 64.974 20020809; UK PL 00037/0403 20030721
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Connect with Social Media:

`abc